Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 25, 2025 09:15 ET | Source: Research and Markets

Regenerative Drugs Market Review 2020-2024 and Forecast 2025-2030: A $29 Billion Opportunity Led by Baxter International, Stryker Corporation and Medtronic

Dublin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The "Regenerative Drugs Market - Forecasts from 2025 to 2030" has been added to ResearchAndMarkets.com's offering. The Global Regenerative Drugs Market...
August 15, 2025 11:07 ET | Source: Research and Markets

Stem Cell Banking Market Report 2025-2033 | Major Companies Like CBR Systems, China Cord Blood, and Lifecell Play Crucial Roles by Investing in R&D, Fostering Collaborations, and Driving Awareness

Dublin, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The "Stem Cell Banking Market Report by Product Type, and Region 2025-2033" has been added to ResearchAndMarkets.com's offering. The global stem cell...
July 08, 2025 09:15 ET | Source: Longeveron

Longeveron® Announces U.S. FDA Approval of IND Application for a Phase 2 Pivotal Registration Study Evaluating Laromestrocel as a Treatment of Pediatric Dilated Cardiomyopathy (DCM)

FDA approves Longeveron's Investigational New Drug (IND) application for stem cell therapy as a potential treatment for pediatric dilated cardiomyopathy.
June 26, 2025 09:05 ET | Source: Longeveron

Longeveron® Appoints Than Powell as Chief Business Officer

Than Powell appointed as Longeveron CBO to lead overall business strategy, Alzheimer's program partnering and HLHS program international strategy.
June 09, 2025 09:15 ET | Source: Longeveron

Longeveron® to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

Longeveron CEO Wa’el Hashad will present at the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference.
May 20, 2025 09:15 ET | Source: Longeveron

Longeveron® to Attend BIO International Convention 2025

Longeveron to host Alzheimer's disease program partnering meetings at BIO 2025 conference June 16-19. Positive Phase 2a data published in Nature Medicine.
May 12, 2025 07:15 ET | Source: Longeveron

Longeveron® Named XPRIZE Healthspan Semifinalist and Top 40 Milestone 1 Award Recipient

Longeveron selected as a Semi-Finalist Team and one of the Top 40 Teams receiving a $250,000 Milestone 1 Award in the XPRIZE Healthspan competition.
May 08, 2025 16:05 ET | Source: Longeveron

Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update

Longeveron announces Q1 2025 financial results & provides business update. Pivotal Phase 2 clinical trial achieves 95% enrollment. Expected full enroll Q2.
April 22, 2025 16:05 ET | Source: Longeveron

Longeveron® Issues Letter to Shareholders Highlighting Corporate Strategy, Recent Progress and Key Priorities and Goals for 2025

Longeveron issues letter to shareholders highlighting corporate strategy, recent progress and 2025 key priorities and goals.
March 18, 2025 10:43 ET | Source: Research and Markets

Stem Cell Therapy Market Global Forecast 2025-2030: Breakthroughs in Gene Editing & Cell Therapy Propel Stem Cell Market Expansion to 2030

Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "Stem Cell Therapy Market by Therapy Type (Allogeneic Therapy, Autologous Therapy), Cell Source (Adult Stem Cells, Embryonic Stem Cells, Induced...